Between 2008/09 and 2012/13 the molecular epidemiology of non-typeable 23
Introduction 34
Non-typeable Heamophilus influenzae (NTHi) is a Gram-negative, human 35 nasopharyngeal bacterium. Most research has leant towards the capsulated 36
Haemophilus influenzae, in particular to serotype B, due to its capacity for 37 causing severe invasive infections such as meningitis and septicemia 1 . H. 38 influenzae type b (Hib) clinical disease has reduced with the widespread use 39 of specific conjugate vaccines 1 . The global mortality and morbidity from NTHi, 40 which predominantly replaced serotype B in nasopharyngeal carriage 2 is 41 significant. This includes the association with acute otitis media (AOM) 3 and in 42 exacerbations of chronic lung conditions such cystic fibrosis 4,5 and chronic 43 obstructive pulmonary disease 6 . Importantly NTHi is now also the leading 44 cause of invasive H. influenzae disease. Examining the burden in 12 EU/EEA 45 countries between 2007 and 2014, NTHi accounted for 78% of the 8,781 46 cases of invasive disease with the burden highest in infants and those ≥60 47 years of age 7 . The former increase was largely down to a concerning 6.2% 48 (95% CI 2.8% to 9.8%) annual increase in neonatal disease notification 7 . 49 50 There is evidence to suggest that the epidemiology of NTHi carriage and 51 associated disease has been altered as a consequence of the introduction of 52 pneumococcal conjugate vaccines (PCVs). This includes an increased NTHi 53 incidence in children with AOM 8-10 as well as increased nasopharyngeal 54 carriage in children who have received PCV 11,12 although it is important to 55 note this is not a ubiquitous phenomenon 13 (Table 1) . Of these, 99.27% (n=273) were classified 88 as NTHi using in silico capsular analysis. Three of these were bexB/bexA +/-89 and therefore classifiable as capsular deficient 16 . The two non-NTHi isolates 90
were classified as serotype f. 91 92 Carriage prevalence for NTHi ranged from 14.63% in 2008/9 to 22.65% in 93 2010/11 with a mean of 18.03% (95% CI 17.58 -18.48) ( Table 1 and Figure  94 1). Using a multivariable, binomial logistic regression model there was higher 95 carriage prevalence of NTHi in the post-PCV13 years of 2010/11 and 2012/13 96 (p < 0.05), but not 2011/12, compared to the pre-PCV13 years. Children that 97 carried NTHi were older (p < 0.05) ( In total 119 NTHi individual multi-locus sequence types (MLSTs) were 115 identified ( Figure 2 ). MLST diversity, as measured using Simpsons (1-D), 116
within each year was high, ranging from 0.97 in 2008/09 to 0.99 in 2010/11 117 and 2011/12 respectively. To determine whether there had been an increase 118 in NTHi MLST diversity following PCV13 introduction the first two and the last 119 two years were grouped as pre-and post-PCV13 eras respectively. The 120 middle year of 2010/11 was excluded in this analysis as we hypothesised this 121 may represent an interim perturbed NTHi population not truly reflective of a 122 post-PCV13 era. Although a slight increase in diversity was noted ( Figure 2 ) 123 this was not statistically significant. 124
125
The NTHi population can be defined by 11 discrete and temporally stable 126 lineages 127 Figure 3 shows the population structure for 266 NTHi carriage isolates for 128 which genomic data was available (those excluded having a sequencing 129 depth equating to less than 30-fold coverage) in combination with an 130 additional 89 isolates which had previously been used to identify six 131 phylogenetic clusters 17 . The total core genome alignment length represented 132 only 313 Kbp (16%) of the on average 1.92 Mbp genome. HierBAPS analysis 133 revealed eleven lineages of NTHi. The polyphyletic lineage 9 was the most 134 predominant (n=54; 19.6% of the carriage isolates) with the fewest being five 135 isolates belonging to lineage 2. All of the 89 additional isolates were classified 136 concordantly with their six previously identified clusters, but with additional 137 delineation. Isolates belonging to cluster IV were further separated into 138 lineages 2 and 11, cluster V into lineages 8 and 4, and cluster VI as lineages 139 6,7 or 9 (Supplementary Data 1). 140
141
We sought to address the paradox of an apparently highly diverse collection 142 of NTHi, based on number of STs identified, within relatively few lineages. We 143 hypothesised that the intra-lineage diversity is balanced by a stable population 144 structure at a higher level of clustering. Here Bray-Curtis dissimilarity was 145 used to account for both lineage presence and abundance between years. As 146 shown in Figure 4 unique MLSTs from 54 lineage 9 isolates, which was also the most frequently 153 observed, to lineage 2, which consisted of just five isolates of ST411. The 154 most common STs encountered were ST57 (n=15, lineage 11), ST201 (n=11, 155 lineage 5) and ST12 (n=11, lineage 8). Lineage prevalence was not a good 156 predictor of intra-lineage diversity measured by Simpsons 1-D (Table 2) In the years preceding and following PCV13 introduction there was little 162 change in the co-carriage of any one particular NTHi lineage with S. 163 pneumoniae ( Figure 6 ). However, lineage 6 had an OR for co-carriage of 164 14.75 (95% CI: 3.14-69.38) and 16.95 (95% CI: 0.93-309.96) in these two 165 periods, with the former being statistically significant (p < 0.001) indicating a 166 correlation between the carriage of this lineage of NTHi and S. pneumoniae; 167 co-carriage was found for 87.5% and 100% isolates respectively Interestingly 168 these increased odds were significant in the two years prior to PCV13 until 169 2010/11, when we predict the impact of PCV13 may have begun, whereupon 170 this relationship was altered ( Figure 6 ). Pre-PCV13, 31.3% (5/18) of lineage 6 171 isolates were co-carried with vaccine serotype pneumococci (serotypes 6B, 172
19A and 7F). In comparison only 8, lineage 6 isolates were found in the 173 following three post-PCV13 years. The absence of VT pneumococci in this 174 period coupled with a lower isolate number leaves this potential impact of 175 PCV13 open to interpretation. By contrast, in the pre-PCV13 era lineage 11 176 exhibited a negative association with S. pneumoniae (OR 0.12 95% CI: 0.05-177 1.01 p = 0.05) however this was not statistically significant in the post-PCV13 178 era. 179 180
Diverse levels of recombination exist between NTHi lineages 181
Within the lineages identified here an almost universally high degree of 182 recombination was observed (Table 3) . Although recombination occurred on 183 average 25% less often than mutation (Ρ/θ 0.742, 95% CI: 0.713-0.771), it 184 produced 19 times (r/m 19.075 95% CI: 17.38-20.77) more substitutions than 185 de novo mutation. Exceptions included lineages 1, 7 and 9 which had 186 significantly lower relative impacts of recombination with r/m values of 3.467 187 (p = 0.0002), 10.642 (p = 0.0267) and 4.651 (p = 0.0005) respectively. In 188 addition, lineage 10 had a Ρ/θ of 1.103 indicating recombination occurred 189 approximately 10% more often than mutation and this caused 56 times more 190 substitutions. MLST diversity within each lineage was correlated to r/m such 191 that lineages with lower Simpsons 1-D (and thus greater diversity) were 192 shown to also have higher r/m (r(10) 0.733 p < 0.001). 193
194
Recombination hot-spots are characterised by involvement in metabolic 195
/ biosynthetic pathways 196
Recombination across the core genome is shown in Figure 7A and is mapped 197 against a maximum-likelihood core genome phylogeny. Here recombination is 198 shown by dark blue and mutation as white. The variability between lineages is 199 clear, as is the non-uniformity of recombination across the core genome 200 alignment. This variability is illustrated in Figure 7B where recombination 201 blocks are counted and plotted according to position in the alignment. Each 202 of the eleven lineages were also analysed separately, these can be found as 203
Supplementary Figures 3 to 13. 204
Seven regions are shown to contain recombination counts above the 95% 205 inter-quartile range. Annotations of these are shown in Figure 7C . The 206 predominant characteristic of these loci is the significant representation of 207 genes involved in metabolic and biosynthesis pathways. These include 208 selenoprotein biosynthesis (selA1-2, selB), amino acid metabolism and 209 scavenging (pepB, ilvE, hisC2, grxB, art, hpt, cydD), carbon source utilisation 210 (metK1/2, lidP) and protein formation and transport (dsbC, yhbE, msbA, 211 yidD/C, ppiD). Several genes that a play role in responses to nutrient 212 availability / stress were also noted and included narL which mediates nitrate-213 response transcriptional regulation 18 , the DNA repair-associated genes recF1 214 and recF2, and adenylate cyclase (cyaD) which controls competence. Of note 215 is that only one gene associated with outer membrane proteins was identified 216 within these seven regions; ompA which encodes outer membrane protein P5. 217 218
Prevalence of antibiotic resistance genes is low except for b-lactamase-219 negative ampicillin resistance (BLNAR) mutations in ST411 of lineage 2 220
The identification of antibiotic resistance genes is shown in Figure 8 . Alleles 221 for spectinomycin resistance and the multi-drug efflux pump, hmrM were 222 found to be near ubiquitous at 96% (n=257) and 98% (n=262) of isolates 223 respectively. APH(3) alleles for aminoglycoside resistance were found in less 224 than 2% (n=5) of isolates which included STs from lineages six (ST932 and 225 264) seven (ST154), eight (ST3 and 142) and nine (ST1411). One of these 226 isolates (a lineage eight, ST3 from 2012/13) was also positive for catII 227 (chloramphenicol), tet and tetD. The same isolate carried resistance to 228 sulphonamide (sul2) as did one other, a lineage seven, ST154 from 2008/09. We also observed that in the pre-PCV13 era, NTHi carriage was more 264 associated with carried pneumococcal serotypes that would ultimately be 265 targeted by PCV13 (19A, 6 and 11) compared to non-VT strains. Data from 266 previous studies have shown similar trends demonstrating that PCV13 267 serotypes were more associated with Haemophilus carriage in contrast to 268 non-PCV13 serotypes 14 . This suggests there are serotype-dependent 269 carriage dynamics between these bacterial species. A plausible outcome of 270 vaccination is that PCV disrupts these associations. We believe this is the first 271 There are a number of limitations to this study. Firstly, the sampling is limited 300 to one geographical region and a defined, narrow subset of the population 301 (children <5 years of age). The extrapolation of the genomic population 302 structure detailed in this study to wider isolate collections must therefore be 303 done with caution, although similar, low numbers of lineages have previously 304 been identified from much broader isolate collections 17,21,29 . The most striking 305 feature of temporal stability is one that can be addressed in future with 306 continued sampling from our paediatric outpatient population. Lastly these 307 isolates are all from carriage and may not be representative of the genotypic 308 diversity associated with disease. It will be interesting for future work to 309 compare the diversity between strains isolated from chronic and acute 310 pathologies from both children and older age cohorts. 311
312
The use of PCVs have radically reduced the burden of invasive 313 pneumococcal disease (IPD) both in the UK 30 and globally 31-37 . In the UK, this 314 IPD reduction has occurred in the absence of any loss of overall 315 pneumococcal carriage prevalence 38,39 , and is a consequence of serotype 316 replacement. The lack of penetrance between carriage replacement with non-317 VT serotypes and IPD is a consequence of lower invasiveness in the non-VT 318 pneumococci 40 . Regardless, the replacement of VT pneumococci represents 319 a disruption in nasopharyngeal microflora. Evidence for indirect effects 320 associated with PCV on Haemophilus disease and carriage have been noted 321 8-12 and PCV vaccination in the very young (<12 months) has been shown to 322 cause a more disordered nasopharyngeal microbiota 41, 42 . We hypothesise 323 that this niche disruption, in combination with the adaptation of S. pneumoniae 324 to maintain its relative fitness in the face of selective pressures in response to 325 Lineage 6 pre-PCV13 was significantly (* p = 0.007) associated with carriage 711 of S. pneumoniae. In the same period lineage 11 was significantly (* p = 0.05) 712 associated with non-carriage of S. pneumoniae. These two associations were 713 not present in the post-PCV13 era. Inset is shown the odds ratio for co-714 higher (p = 0.01) than that of all participants. §Age records for 37 participants 804 were not available. a 95% CIs are shown in parentheses. 805 806 
